Pacific Global Investment Management CO Abbott Laboratories Transaction History

Pacific Global Investment Management CO

$529 Million
Q3 2024

A detailed history of Pacific Global Investment Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Pacific Global Investment Management CO holds 24,984 shares of ABT stock, worth $3.2 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

24,984

Previous 25,001 0.07%

Holding current value

$3.2 Million

Previous $2.6 Million 9.66%

% of portfolio

0.54%

Previous 0.51%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $1,701 - $2,008	-17 Reduced 0.07%	24,984 $2.85 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $10,778 - $12,031	-107 Reduced 0.43%	25,001 $2.6 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $22,999 - $25,401	-210 Reduced 0.83%	25,108 $2.85 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $18,398 - $22,521	-204 Reduced 0.8%	25,318 $2.79 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $19,201 - $23,038	-201 Reduced 0.78%	25,522 $2.47 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $8,263 - $9,207	-82 Reduced 0.32%	25,723 $2.8 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $4,455 - $5,244	46 Added 0.18%	25,805 $2.61 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $6,559 - $7,694	-69 Reduced 0.27%	25,759 $2.83 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $1,257 - $1,456	13 Added 0.05%	25,828 $2.5 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $16,331 - $19,739	-160 Reduced 0.62%	25,815 $2.81 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $7,753 - $9,454	-68 Reduced 0.26%	25,975 $3.07 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $3,465 - $4,243	30 Added 0.12%	26,043 $3.67 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $46,780 - $51,753	-401 Reduced 1.52%	26,013 $3.07 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $20,840 - $24,532	-197 Reduced 0.74%	26,414 $3.06 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $31,345 - $36,930	-288 Reduced 1.07%	26,611 $3.19 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $441,000 - $480,564	4,200 Added 18.5%	26,899 $2.95 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $40,413 - $49,078	441 Added 1.98%	22,699 $2.47 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $82,925 - $106,134	1,083 Added 5.11%	22,258 $2.04 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $143,732 - $210,175	-2,288 Reduced 9.75%	21,175 $1.67 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $27,871 - $31,027	355 Added 1.54%	23,463 $2.04 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $1,718 - $1,863	-21 Reduced 0.09%	23,108 $1.93 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $6,486 - $7,565	-89 Reduced 0.38%	23,129 $1.95 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $12,118 - $14,650	-183 Reduced 0.78%	23,218 $1.86 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $13,898 - $15,745	-212 Reduced 0.9%	23,401 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $6,749 - $8,142	-111 Reduced 0.47%	23,613 $1.73 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $30,281 - $33,422	-526 Reduced 2.17%	23,724 $1.45 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $13,842 - $15,650	-246 Reduced 1.0%	24,250 $1.45 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $5,582 - $5,976	104 Added 0.43%	24,496 $1.4 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $35,516 - $39,639	-739 Reduced 2.94%	24,392 $1.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,131	25,131 $1.22 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Global Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Global Investment Management CO with notifications on news.

Account

Pacific Global Investment Management CO Abbott Laboratories Transaction History